Xia Y, Zhang E, Hu Y
Tumor Hospital, Sun Yat-Sen University of Medical Sciences, Guangzhou.
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1996;31(3):168-70.
Seventy-eight patients with nasopharyngeal carcinoma were equally divided into two groups: 39 patients were treated by HPD plus radiation and 39 patients by radiation alone. Immunological functions were evaluated in each patient before and after radiation. The results showed that (1) in patients treated by RPD and radiation, no statistical difference was observed on immunological functions before and after treatment; (2) in patients treatd by radiation alone, the immunological functions, including OKT3, OKT4, OKT4/OKT8 ratio and lymphocyte transformation, were significantly decreased after treatment. These findings indicate that the immunological functions in patients with nasopharyngeal carcinoma could be protected by HPD during radiotherapy.
78例鼻咽癌患者被平均分为两组:39例患者接受血卟啉衍生物(HPD)加放疗治疗,39例患者仅接受放疗。在放疗前后对每位患者的免疫功能进行评估。结果显示:(1)接受血卟啉衍生物(RPD)加放疗治疗的患者,治疗前后免疫功能无统计学差异;(2)仅接受放疗的患者,治疗后免疫功能,包括OKT3、OKT4、OKT4/OKT8比值和淋巴细胞转化率均显著降低。这些发现表明,鼻咽癌患者的免疫功能在放疗期间可通过血卟啉衍生物(HPD)得到保护。